News · EXPLAINER
Injective RWA perpetuals provide price exposure, not direct asset ownership
Injective offers perpetual markets linked to equities, commodities and other references. Understanding the derivative is essential before treating that exposure as ownership of an underlying asset.
Published by
RWA Wire Editorial Desk
Coverage standard
Independent // Source-led
Corrections & tips
Contact the desk →
What the product is
Injective describes its RWA perpetual markets as contracts referencing equities, commodities, currencies and indices. Its TradFi index announcement identifies a perpetual market available through Helix. These are derivative products; the existence of a stock reference does not make the contract an ordinary company share.
Why the label needs unpacking
“RWA” can describe more than one product structure. A token representing a claim on a held asset and a derivative tracking a reference price answer different investor needs. They should not be combined into an undifferentiated count of tokenized ownership.
For a perpetual market, the relevant documentation is the contract’s pricing, margin, funding and settlement rules. For a backed token, the relevant documents include custody and the holder’s legal claim.
The editorial takeaway is to identify the instrument before interpreting trading figures. Volume in a stock-linked derivative does not establish how many shares have been brought onchain or how many investors hold ownership claims on those shares.
Sources
Key takeaways
- //Perpetual exposure differs from holding the referenced asset.
- //Product structure matters more than an RWA label.
Explore this topic
Continue through RWA Wire's connected research map.
RWA Wire // Intelligence Network
Infrastructure connected to this story
Continue researching
Go from this story to the background, infrastructure and adjacent market developments that explain it.
Explore all topics →